Sub-Total: $0.00
ANCC
Showing 1–16 of 45 results
-
3rd Annual Symposium on Individualized Novel Disease-Modifying Treatment Options for Multiple Sclerosis
Read more -
Advances in Biological Therapies for Atopic Dermatitis in Adults and Children
Read more -
Advances in Biological Therapy of Crohn’s Disease and Ulcerative Colitis
Read more -
Advances in GLP-1 Receptor Agonists, Insulins and SGLT-2 Inhibitors in the Treatment of Diabetes
Read more -
Advances in Identifying the Diagnostic Pitfalls and New Therapies in the Clinical Practice of CIDP
Read more -
Advances in Identifying the Diagnostic Pitfalls and New Therapies in the Clinical Practice of CIDP
Read more -
Advances in the Diagnosis and Treatment of Eosinophilic Esophagitis
Read more -
Biological Therapies for PsA, Osteoarthritis, SLE and Spondyloarthritis: Comparative Effectiveness Based on Treatment Profiles and ACR/EULAR Recommendations
Read more -
Biosimilars: Implications for Clinical Practice in Inflammatory Bowel Diseases
Read more -
Changing Landscape of Biological Therapies for Psoriasis: Promising Efficacy of Interleukin-17 (IL-17) and IL-2 Pathway Inhibitors
Read more -
Changing Landscape of GLP-1 Receptor Agonists on Glycemic Control, Weight Reduction and Cardiovascular Outcomes in Individuals with Diabetes
Read more -
Changing Landscape of Management in Eye Diseases: Glaucoma, Ocular Surface Disease, Neurotrophic Keratitis, Cataract Surgery, and Vitreoretinal Surgery
Read more -
Changing Landscape of Management in Eye Diseases: Glaucoma, Ocular Surface Disease, Neurotrophic Keratitis, Cataract Surgery, and Vitreoretinal Surgery
Read more -
Changing Landscape of Treatment Options for Migraine with Monoclonal Antibodies Targeting Calcitonin Gene-related Peptide (CGRP) Pathway or its Receptor
Read more -
Efficacy and Safety of Fixed-ratio Combination of Insulin Degludec and Liraglutide (IDegLira) and Insulin Glargine and Lixisenatide (IGlarLixi) in Patients with Type 2 Diabetes
Read more -
Emerging Anti-Interleukin 5 (IL-5) and IL-5Ra Based Biological Therapies: Efficacy, Safety and Future Perspectives in Severe Eosinophilic Asthma
Read more
